Cystatin C deficiency in human atherosclerosis and aortic aneurysms
Summary
This summary is machine-generated.Cystatin C deficiency is linked to vascular diseases like atherosclerosis and aortic aneurysms. Lowering cystatin C levels may promote arterial wall damage by unbalancing proteases.
Area Of Science
- Vascular Biology
- Protease Inhibitor Function
- Atherosclerosis Pathogenesis
Background
- Atherosclerosis and abdominal aortic aneurysm involve elastic lamina breakdown.
- Elastolytic cysteine proteases (cathepsins S and K) are upregulated at sites of arterial elastin damage.
- The role of endogenous inhibitors, like cystatin C, in counterbalancing these proteases in vascular disease is unclear.
Purpose Of The Study
- To investigate the expression and role of cystatin C in vascular wall remodeling.
- To determine if cystatin C levels correlate with abdominal aortic aneurysm progression.
- To assess the impact of cystatin C on protease activity in vitro.
Main Methods
- Analysis of cystatin C expression in vascular smooth muscle cells (SMCs) from atherosclerotic and aneurysmal lesions.
- Ultrasonographic screening of 122 patients to correlate abdominal aortic diameter with serum cystatin C levels.
- In vitro experiments using cytokine-stimulated vascular SMCs treated with TGF-beta(1) to induce cystatin C secretion and assess cathepsin activity.
Main Results
- Cystatin C, normally present in vascular SMCs, was significantly reduced in atherosclerotic and aneurysmal aortic lesions.
- A significant inverse correlation was observed between abdominal aortic diameter and serum cystatin C levels in patients.
- TGF-beta(1) induction of cystatin C secretion in vitro effectively blocked the elastolytic activity of cathepsins secreted by SMCs.
Conclusions
- An imbalance between cysteine proteases and cystatin C may play a critical role in arterial wall remodeling.
- Cystatin C deficiency is a feature of vascular disease, particularly in atherosclerosis and abdominal aortic aneurysms.
- Restoring cystatin C levels could be a potential therapeutic strategy for vascular diseases characterized by elastin degradation.
View abstract on PubMed